| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/20/2011 | US8080659 CXCR4 antagonists including diazine and triazine structures for the treatment of medical disorders |
| 12/20/2011 | US8080657 Compounds of reverse turn mimetics and the use thereof |
| 12/20/2011 | US8080651 Juvenile hemochromatosis gene (HFE2A), expression products and uses thereof |
| 12/20/2011 | US8080641 Process for the production of multiple cross-linked hyaluronic acid derivatives |
| 12/20/2011 | US8080584 Delayed release rasagiline citrate formulation |
| 12/20/2011 | US8080583 Emulsion cosmetic compositions containing resveratrol derivatives and linear or branched silicone |
| 12/20/2011 | US8080582 Derivatives of 8-epiblechnic acid and their effects on down-regulation of endothelin (ETA) receptor mRNA |
| 12/20/2011 | US8080581 Cosmetics |
| 12/20/2011 | US8080580 Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives |
| 12/20/2011 | US8080579 Compositions and methods for treatment of inflammatory bowel disease |
| 12/20/2011 | US8080578 Methods for treatment with bucindolol based on genetic targeting |
| 12/20/2011 | US8080577 Diindolylmethane formulations for the treatment of leiomyomas |
| 12/20/2011 | US8080576 Compounds for enzyme inhibition |
| 12/20/2011 | US8080575 Gamma-lactam compounds for promoting bone growth |
| 12/20/2011 | US8080574 PDK-1/Akt signaling inhibitors |
| 12/20/2011 | US8080573 Heterocycle substituted amide and sulfur amide derivatives as histone deacetylase (hdac) inhibitors |
| 12/20/2011 | US8080572 Dual-acting antihypertensive agents |
| 12/20/2011 | US8080571 Tricyclic angiotensin II agonists |
| 12/20/2011 | US8080570 α2B and α2C agonists |
| 12/20/2011 | US8080569 Imidazo[2,1-b]thiazoles and their use as pharmaceuticals |
| 12/20/2011 | US8080568 2-pyridyl substituted imidazoles as therapeutic ALK5 and/or ALK4 inhibitors |
| 12/20/2011 | US8080567 EP2 receptor agonists |
| 12/20/2011 | US8080566 Carbazole inhibitors of histamine receptors for the treatment of disease |
| 12/20/2011 | US8080565 Substituted 4-amino-benzylpiperidine compounds |
| 12/20/2011 | US8080564 Hemodynamics improving agent |
| 12/20/2011 | US8080563 Bicyclic heteroaryl inhibitors of PDE4 |
| 12/20/2011 | US8080562 Crystalline pharmaceutical and methods of preparation and use thereof |
| 12/20/2011 | US8080561 Pyridopyrazines and derivatives thereof as ALK and c-Met inhibitors |
| 12/20/2011 | US8080559 5(S)-(2′-hydroxyethoxy)-20(S)-camptothecin and its preparation and use for the treatment of cancer |
| 12/20/2011 | US8080558 4-(tetrazol-5-yl)-quinazoline derivatives as anti-cancer agent |
| 12/20/2011 | US8080557 Quinazolinedione derivatives as PARP inhibitors |
| 12/20/2011 | US8080556 2-amino pyrimidine compounds as potent HSP-90 inhibitors |
| 12/20/2011 | US8080555 Purine derivatives and their use for treatment of autoimmune diseases |
| 12/20/2011 | US8080554 Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation |
| 12/20/2011 | US8080553 Methods and reagents for the treatment of immunoinflammatory disorders |
| 12/20/2011 | US8080552 Pyrimidyl derivatives as protein kinase inhibitors |
| 12/20/2011 | US8080551 HIV inhibiting pyrimidines derivatives |
| 12/20/2011 | US8080550 Anesthetic compositions and methods of use |
| 12/20/2011 | US8080549 Endothelin receptor antagonists |
| 12/20/2011 | US8080548 Dialkylamino alkyl esters of pivagabine as medicaments for the treatment of central nervous system disorders |
| 12/20/2011 | US8080547 Triazolopyridine carboxamide derivatives and triazolopyrimidine carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 12/20/2011 | US8080546 Pyrazolo-pyridinone derivatives and methods of use |
| 12/20/2011 | US8080545 Compounds for enzyme inhibition |
| 12/20/2011 | US8080544 Prodrugs of CGRP receptor antagonists |
| 12/20/2011 | US8080542 S1P receptor modulating compounds and use thereof |
| 12/20/2011 | US8080541 Carbocyclic GlyT-1 receptor antagonists |
| 12/20/2011 | US8080540 Therapeutically active triazoles and their use |
| 12/20/2011 | US8080539 Method of treating human preeclampsia employing resibufagenin |
| 12/20/2011 | US8080538 Method for increasing absorption of steroid hormones |
| 12/20/2011 | US8080537 Combinations of adapalene and benzoyl peroxide for treating acne lesions |
| 12/20/2011 | US8080536 Phosphorus-containing prodrugs |
| 12/20/2011 | US8080535 Hyaluronic acid nutritional supplements and methods of using the same |
| 12/20/2011 | US8080534 Targeting PAX2 for the treatment of breast cancer |
| 12/20/2011 | US8080530 Topical application of ivermectin for the treatment of dermatological conditions/afflictions |
| 12/20/2011 | US8080529 Macrolides with anti-inflammatory activity |
| 12/20/2011 | US8080528 Compositions and methods for treatment of cachexia |
| 12/20/2011 | US8080527 Methods and compositions for prevention and treatment of inflammatory disease, autoimmune disease, and transplant rejection |
| 12/20/2011 | US8080521 Flowable carrier matrix and methods for delivering to a patient |
| 12/20/2011 | US8080431 Nanoparticles |
| 12/20/2011 | US8080266 Water dispersible compositions and methods of using the water dispersible compositions |
| 12/20/2011 | US8080263 Dispersion for pulmonary delivery of a bioactive agent |
| 12/20/2011 | US8080258 Antimicrobial agent |
| 12/20/2011 | US8080254 OB fusion protein compositions and methods |
| 12/20/2011 | US8080241 Viruses for the treatment of cellular proliferative disorders |
| 12/20/2011 | US8080236 Particulate materials |
| 12/20/2011 | CA2733294C Pharmaceutical combination of a tiotropium salt and ciclesonide |
| 12/20/2011 | CA2652299C Substituted beta-phenyl-alpha-hydroxy propanoic acid, synthesis method and use thereof |
| 12/20/2011 | CA2602738C Aminopyrimidine compounds and their salts, process for preparation and pharmaceutical use thereof |
| 12/20/2011 | CA2590224C Method for reduction, stabilization and prevention of rupture of lipid rich plaque |
| 12/20/2011 | CA2574898C Immune modulation and anti-allergy activities of zingiber zerumbet |
| 12/20/2011 | CA2569396C Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 12/20/2011 | CA2540174C Aerosol formulation for inhalation, containing an anticholinergic agent |
| 12/20/2011 | CA2535664C Disinfecting and sanitizing article for hands and skin and hard surfaces |
| 12/20/2011 | CA2527029C Oral cereal beta glucan compositions |
| 12/20/2011 | CA2526211C [1,2,4]triazolo[1,5,a]pyrimidin-2-ylurea derivative and use thereof |
| 12/20/2011 | CA2525037C Microcrystals of (e)-8-(3,4-dimethoxystyryl)-1,3-diethyl-7-methylxanthine |
| 12/20/2011 | CA2524665C Drug delivery system |
| 12/20/2011 | CA2524409C Androgen receptor modulators and methods of use thereof |
| 12/20/2011 | CA2511337C Oxazoles as mglur1 enhancer |
| 12/20/2011 | CA2508226C Novel heterocyclic fluoroglycoside derivatives, pharmaceutical products containing said compounds and the use thereof |
| 12/20/2011 | CA2507926C Pharmaceutical composition comprising chito-oligomers |
| 12/20/2011 | CA2493821C Chondropsin-class antitumor v-atpase inhibitor compounds, compositions and methods of use thereof |
| 12/20/2011 | CA2492924C Novel piperazinone derivates for the treatment of 5-ht2a receptor-related disorders |
| 12/20/2011 | CA2485136C Benzoxazine derivatives as 5-ht6 modulators and uses thereof |
| 12/20/2011 | CA2483464C Method for treating obesity |
| 12/20/2011 | CA2479892C Plasma carboxypeptidase b inhibitors |
| 12/20/2011 | CA2477787C Therapeutic methods and uses of sapogenins and their derivatives |
| 12/20/2011 | CA2468562C Hydrazonopyrazole derivatives and their use as therapeutics |
| 12/20/2011 | CA2464660C Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma |
| 12/20/2011 | CA2453991C New antitumoral derivatives of et-743 |
| 12/20/2011 | CA2450589C Isoxazoline compounds having mif antagonist activity |
| 12/20/2011 | CA2450221C Compounds for the treatment of metabolic disorders |
| 12/20/2011 | CA2427388C Pharmaceutical compositions and uses for improving memory and learning impairments |
| 12/20/2011 | CA2386858C 36p6d5: secreted tumor antigen |
| 12/20/2011 | CA2381143C Dendrimer-photosensitizer complexes for medical applications |
| 12/20/2011 | CA2347387C Vitamin k2 containing food product |
| 12/20/2011 | CA2326777C Aminocyclohexyl ether compounds and uses thereof |
| 12/20/2011 | CA2303394C A delivery of arginine to cause beneficial effects |
| 12/20/2011 | CA2252375C Nucleic acid vaccination for parvoviral infections |
| 12/20/2011 | CA2146235C Process for growing thraustochytriales |